Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets
Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using ste...
Saved in:
Published in | AAPS PharmSciTech Vol. 19; no. 8; pp. 3355 - 3361 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.11.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms. |
---|---|
AbstractList | Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms. Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms. |
Author | Goyanes, Alvaro Gaisford, Simon Martinez, Pamela Robles Basit, Abdul W. |
Author_xml | – sequence: 1 givenname: Pamela Robles surname: Martinez fullname: Martinez, Pamela Robles organization: UCL School of Pharmacy, University College London – sequence: 2 givenname: Alvaro surname: Goyanes fullname: Goyanes, Alvaro organization: UCL School of Pharmacy, University College London – sequence: 3 givenname: Abdul W. surname: Basit fullname: Basit, Abdul W. organization: UCL School of Pharmacy, University College London – sequence: 4 givenname: Simon surname: Gaisford fullname: Gaisford, Simon email: s.gaisford@ucl.ac.uk organization: UCL School of Pharmacy, University College London |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29948979$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kbtOJDEQRa0VaHntB2yCHELQ4LL75RAxy0MaCQRsbHnc5Rkjjz3Y7oC_3x4NSCsCoqrgnCtV3SOyF2JAQn4DuwDO-ssMnNeyYtBXwLqmEj_IITSCVVIKvvfffkCOcn5ljAuQ4ic54FLWvezkIdH3wfoRg0EaLb3FuMaS3mkMtKyQztK4pE_oUWekjyla5zFvweeCCaN3ZRWXSW9WztCz5_nVORWz6jG5UHCgL3rhseQTsm-1z_jrYx6Tvzd_Xq7vqvnD7f311bwyNbBS1QK62thW8kEaHPqu1oa1_cCEsEw0MJ0B2JpFbSV0VnOsBy1Y0wHYRtgBxDE52-VuUnwbMRe1dtmg9zpgHLPirGV910DTTujpBzou1jioTXJrnd7V51smoNsBJsWcE1plXNHFxVCSdl4BU9sC1K4ANRWgtgUoMZnwxfwM_87hOydPbFhiUq9xTGF61jfSP1tQle4 |
CitedBy_id | crossref_primary_10_1080_03639045_2021_1994990 crossref_primary_10_1016_j_ijpharm_2024_124506 crossref_primary_10_3390_pharmaceutics12020124 crossref_primary_10_1208_s12249_020_01905_8 crossref_primary_10_1016_j_ijpx_2023_100159 crossref_primary_10_1016_j_bioadv_2022_213100 crossref_primary_10_1016_j_ijpharm_2022_122046 crossref_primary_10_1007_s41669_024_00551_1 crossref_primary_10_2217_3dp_2020_0031 crossref_primary_10_1016_j_ijpharm_2018_11_025 crossref_primary_10_3390_pharmaceutics14040843 crossref_primary_10_1016_j_xphs_2020_06_027 crossref_primary_10_3390_pharmaceutics11100544 crossref_primary_10_1038_s41467_021_21438_3 crossref_primary_10_3390_pharmaceutics14020281 crossref_primary_10_1080_03639045_2019_1576723 crossref_primary_10_22159_ajpcr_2022_v15i8_45136 crossref_primary_10_1016_j_ijpharm_2021_120257 crossref_primary_10_37285_ijpsn_2023_16_1_7 crossref_primary_10_1016_j_xphs_2021_08_030 crossref_primary_10_1108_RPJ_09_2023_0326 crossref_primary_10_1021_acs_langmuir_3c02626 crossref_primary_10_1016_j_ijpharm_2025_125218 crossref_primary_10_1016_j_jddst_2020_101850 crossref_primary_10_1016_j_ijpharm_2018_08_002 crossref_primary_10_1002_VIW_20200126 crossref_primary_10_1016_j_bprint_2023_e00298 crossref_primary_10_1016_j_ijpharm_2022_122574 crossref_primary_10_1115_1_4056199 crossref_primary_10_1016_j_addma_2020_101071 crossref_primary_10_1016_j_ijpharm_2024_124594 crossref_primary_10_1016_j_ejps_2020_105688 crossref_primary_10_1016_j_matchemphys_2024_129692 crossref_primary_10_3390_polym14245413 crossref_primary_10_2174_1381612825666190507115504 crossref_primary_10_3389_fbioe_2023_1256361 crossref_primary_10_1016_j_apsb_2021_03_015 crossref_primary_10_1007_s42242_021_00175_y crossref_primary_10_3390_pharmaceutics11040148 crossref_primary_10_1016_j_addr_2021_04_020 crossref_primary_10_1089_ten_tea_2019_0278 crossref_primary_10_1016_j_ijpharm_2020_119732 crossref_primary_10_3390_pharmaceutics15092230 crossref_primary_10_29109_gujsc_1601468 crossref_primary_10_1016_j_ijpharm_2019_118471 crossref_primary_10_1016_j_ejpb_2022_06_013 crossref_primary_10_4164_sptj_57_633 crossref_primary_10_3390_app9081713 crossref_primary_10_1208_s12249_019_1538_1 crossref_primary_10_1016_j_bprint_2023_e00289 crossref_primary_10_1016_j_ijpharm_2022_122540 crossref_primary_10_2139_ssrn_4076505 crossref_primary_10_1002_adma_201902516 crossref_primary_10_1016_j_apsb_2021_05_014 crossref_primary_10_1016_j_mtchem_2022_100789 crossref_primary_10_3390_molecules27092784 crossref_primary_10_1080_01932691_2023_2289623 crossref_primary_10_1208_s12249_019_1455_3 crossref_primary_10_1016_j_addr_2021_113921 crossref_primary_10_1016_j_ijpharm_2020_119066 crossref_primary_10_1016_j_sintl_2022_100177 crossref_primary_10_1007_s10856_021_06509_7 crossref_primary_10_1016_j_jconrel_2020_10_008 crossref_primary_10_1088_1758_5090_ad3a14 crossref_primary_10_1016_j_ijpharm_2019_118611 crossref_primary_10_1016_j_mtcomm_2023_105875 crossref_primary_10_3390_pr11123431 crossref_primary_10_1016_j_xphs_2020_08_029 crossref_primary_10_3390_pharmaceutics12090833 crossref_primary_10_1016_j_ijpharm_2019_118494 crossref_primary_10_3390_pharmaceutics12111100 crossref_primary_10_15212_AMM_2021_0010 crossref_primary_10_1016_j_ijpharm_2019_118651 crossref_primary_10_1016_j_ijpharm_2022_121956 crossref_primary_10_1016_j_ijpharm_2023_123058 crossref_primary_10_1021_acs_biomac_4c01004 crossref_primary_10_1016_j_ijpharm_2024_124543 crossref_primary_10_1016_j_stlm_2022_100081 crossref_primary_10_1016_j_foodchem_2024_140348 crossref_primary_10_3390_pharmaceutics11120645 crossref_primary_10_1088_1748_605X_ad2a3a crossref_primary_10_1016_j_apt_2021_07_022 crossref_primary_10_3390_pharmaceutics15020395 crossref_primary_10_1016_j_ijpharm_2020_119245 crossref_primary_10_1021_acs_jafc_3c02608 crossref_primary_10_1016_j_eurpolymj_2024_113245 crossref_primary_10_1016_j_ijpharm_2025_125415 crossref_primary_10_1016_j_addr_2021_114076 crossref_primary_10_1248_bpb_b23_00443 crossref_primary_10_1007_s42242_021_00157_0 crossref_primary_10_1016_j_ijpharm_2022_122135 crossref_primary_10_3390_ma13214961 crossref_primary_10_3390_pharmaceutics14071312 crossref_primary_10_3390_pharmaceutics15041276 crossref_primary_10_1080_09205063_2021_1967702 crossref_primary_10_1007_s40964_020_00127_5 crossref_primary_10_1208_s12249_019_1400_5 crossref_primary_10_3390_pharmaceutics11060274 crossref_primary_10_3390_pharmaceutics16101285 crossref_primary_10_3390_jmmp9010011 crossref_primary_10_1016_j_mfglet_2024_09_109 crossref_primary_10_1016_j_ijpharm_2019_118790 crossref_primary_10_1016_j_ijpharm_2021_120442 crossref_primary_10_1016_j_bprint_2024_e00360 crossref_primary_10_1016_j_ijpharm_2021_120721 crossref_primary_10_1007_s12247_022_09684_4 crossref_primary_10_1021_acs_langmuir_4c00894 crossref_primary_10_1016_j_mtcomm_2023_107987 crossref_primary_10_3390_pharmaceutics13050616 crossref_primary_10_1016_j_jconrel_2022_09_023 crossref_primary_10_37349_emed_2023_00161 crossref_primary_10_1016_j_ejps_2019_05_008 crossref_primary_10_1080_03639045_2020_1801714 crossref_primary_10_1016_j_ijpharm_2023_122780 crossref_primary_10_3390_ph16111521 crossref_primary_10_1016_j_ijpharm_2018_07_024 crossref_primary_10_1016_j_eurpolymj_2023_112240 crossref_primary_10_1016_j_jddst_2021_102992 crossref_primary_10_3390_pharmaceutics13091524 crossref_primary_10_1016_j_ijpharm_2020_119428 crossref_primary_10_1016_j_jconrel_2019_04_021 crossref_primary_10_3389_fphar_2021_646836 crossref_primary_10_1016_j_ijpharm_2020_119820 crossref_primary_10_3390_pharmaceutics11080390 crossref_primary_10_1080_17425247_2019_1660318 crossref_primary_10_52711_0974_360X_2024_00720 crossref_primary_10_1007_s11095_018_2531_1 crossref_primary_10_1248_bpb_b19_00481 crossref_primary_10_3390_s20174733 crossref_primary_10_1016_j_ijpharm_2023_122895 crossref_primary_10_1016_j_susmat_2022_e00481 crossref_primary_10_1016_j_ijpx_2022_100142 crossref_primary_10_3390_pharmaceutics15071917 crossref_primary_10_3390_pharmaceutics15020416 crossref_primary_10_3390_polym12051105 crossref_primary_10_2174_0113816128309717240826101647 crossref_primary_10_1021_acs_molpharmaceut_2c01061 crossref_primary_10_1016_j_ijpharm_2020_119825 |
Cites_doi | 10.1016/S0939-6411(99)00082-X 10.1016/j.ejpb.2011.01.001 10.1016/j.ijpharm.2016.03.016 10.1016/j.drudis.2018.05.025 10.1081/DDC-120003007 10.1016/j.ijpharm.2015.02.051 10.1023/A:1016218716951 10.1166/jbn.2009.1052 10.1016/j.ijpharm.2017.07.064 10.1016/j.ijpharm.2015.04.069 10.1023/A:1015834114359 10.1016/S0014-827X(02)01297-1 10.1016/j.ijpharm.2018.02.015 10.1016/J.IJPHARM.2017.06.082 10.1016/S0928-0987(98)00029-3 10.1016/j.ijpharm.2017.09.003 10.1016/j.ejpb.2014.12.003 10.1016/j.ijpharm.2014.04.019 10.1080/10717540490265379 10.1016/J.TIPS.2018.02.006 10.1002/9783527648245.ch1 10.1016/j.ijpharm.2009.08.003 10.1016/j.ijpharm.2018.05.044 |
ContentType | Journal Article |
Copyright | American Association of Pharmaceutical Scientists 2018 |
Copyright_xml | – notice: American Association of Pharmaceutical Scientists 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1208/s12249-018-1075-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1530-9932 |
EndPage | 3361 |
ExternalDocumentID | 29948979 10_1208_s12249_018_1075_3 |
Genre | Journal Article |
GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67N 6J9 6NX 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAKDD AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACKNC ACMDZ ACMJI ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG AOIJS ARMRJ AXYYD B-. BA0 BAWUL BDATZ BGNMA BSONS C1A CAG COF CS3 CSCUP DDRTE DIK DNIVK DPUIP E3Z EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GX1 H13 HG6 HH5 HMJXF HRMNR HYE HZ~ IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LGEZI LLZTM LOTEE M4Y MA- NADUK NPVJJ NQJWS NU0 NXXTH O9- O93 O9I O9J OK1 OVD P2P PF0 PT4 QOR QOS R89 R9I ROL RPM RPX RSV S16 S1Z S27 S3A S3B SAP SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TEORI TR2 TSG TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XSB YLTOR Z45 Z7U Z7V Z7W Z7X Z81 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c410t-43174cf692d9ced874ac068d033f03519931e6cb4f917fa2e4da305711f53fd13 |
IEDL.DBID | U2A |
ISSN | 1530-9932 |
IngestDate | Fri Jul 11 15:05:04 EDT 2025 Wed Feb 19 02:35:13 EST 2025 Thu Apr 24 23:09:08 EDT 2025 Tue Jul 01 01:45:32 EDT 2025 Fri Feb 21 02:33:07 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | additive manufacturing acetaminophen tablets three-dimensional printing stereolithography |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c410t-43174cf692d9ced874ac068d033f03519931e6cb4f917fa2e4da305711f53fd13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 29948979 |
PQID | 2060875156 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2060875156 pubmed_primary_29948979 crossref_citationtrail_10_1208_s12249_018_1075_3 crossref_primary_10_1208_s12249_018_1075_3 springer_journals_10_1208_s12249_018_1075_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: United States |
PublicationSubtitle | An Official Journal of the American Association of Pharmaceutical Scientists |
PublicationTitle | AAPS PharmSciTech |
PublicationTitleAbbrev | AAPS PharmSciTech |
PublicationTitleAlternate | AAPS PharmSciTech |
PublicationYear | 2018 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Fina, Goyanes, Madla, Awad, Trenfield, Min Kuek (CR24) 2018; 547 Goyanes, Hatton, Merchant, Basit (CR15) 2015; 484 Liu, Merchant, Kulkarni, Alkademi, Basit (CR12) 2011; 78 Kim (CR21) 1995; 12 Fina, Madla, Goyanes, Zhang, Gaisford, Basit (CR23) 2018; 541 Goyanes, Scarpa, Kamlow, Gaisford, Basit, Orlu (CR9) 2017; 530 Parojcić, Durić, Jovanović, Ibrić (CR19) 2004; 11 Reynolds, Mitchell, Balwinski (CR20) 2002; 28 Wang, Goyanes, Gaisford, Basit (CR16) 2016; 503 Fina, Goyanes, Gaisford, Basit (CR8) 2017; 529 Awad, Trenfield, Goyanes, Gaisford, Basit (CR7) 2018; 23 Goyanes, Buanz, Hatton, Gaisford, Basit (CR18) 2014; 89 Kim (CR22) 1999; 7 Skoug, Borin, Fleishaker, Cooper (CR4) 1991; 8 Trenfield, Awad, Goyanes, Gaisford, Basit (CR1) 2018; 39 Raju, Prakash, Rao, Reddy, Sreenivasulu, Narasu (CR6) 2010; 3 Karasulu, Ertan (CR3) 2002; 57 Fouassier, Lalevée (CR11) 2012 Karasulu, Ertan, Köse (CR5) 2000; 49 Goyanes, Martinez, Buanz, Basit, Gaisford (CR10) 2015; 494 Fadda, Merchant, Arafat, Basit (CR13) 2009; 382 Varum, Merchant, Goyanes, Assi, Zboranová, Basit (CR14) 2018; 468 Martinez, Goyanes, Basit, Gaisford (CR17) 2017; 532 Gökçe, Özyazici, Ertan (CR2) 2009; 5 PN Raju (1075_CR6) 2010; 3 A Goyanes (1075_CR9) 2017; 530 SJ Trenfield (1075_CR1) 2018; 39 HY Karasulu (1075_CR3) 2002; 57 F Fina (1075_CR23) 2018; 541 F Varum (1075_CR14) 2018; 468 HM Fadda (1075_CR13) 2009; 382 J Parojcić (1075_CR19) 2004; 11 C Kim (1075_CR21) 1995; 12 C Kim (1075_CR22) 1999; 7 JW Skoug (1075_CR4) 1991; 8 A Goyanes (1075_CR15) 2015; 484 JP Fouassier (1075_CR11) 2012 PR Martinez (1075_CR17) 2017; 532 F Liu (1075_CR12) 2011; 78 Atheer Awad (1075_CR7) 2018; 23 J Wang (1075_CR16) 2016; 503 HY Karasulu (1075_CR5) 2000; 49 F Fina (1075_CR8) 2017; 529 TD Reynolds (1075_CR20) 2002; 28 A Goyanes (1075_CR18) 2014; 89 A Goyanes (1075_CR10) 2015; 494 EH Gökçe (1075_CR2) 2009; 5 F Fina (1075_CR24) 2018; 547 |
References_xml | – volume: 49 start-page: 177 year: 2000 end-page: 182 ident: CR5 article-title: Modeling of theophylline release from different geometrical erodible tablets publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(99)00082-X – volume: 78 start-page: 151 year: 2011 end-page: 157 ident: CR12 article-title: Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2011.01.001 – volume: 3 start-page: 872 year: 2010 end-page: 876 ident: CR6 article-title: Effect of tablet surface area and surface area/volume on drug release from lamivudine extended release matrix tablets publication-title: Int J Pharm Sci Nanotech – volume: 503 start-page: 207 year: 2016 end-page: 212 ident: CR16 article-title: Stereolithographic (SLA) 3D printing of oral modified-release dosage forms publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2016.03.016 – volume: 23 start-page: 1547 issue: 8 year: 2018 end-page: 1555 ident: CR7 article-title: Reshaping drug development using 3D printing publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2018.05.025 – volume: 28 start-page: 457 year: 2002 end-page: 466 ident: CR20 article-title: Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets publication-title: Drug Dev Ind Pharm doi: 10.1081/DDC-120003007 – volume: 484 start-page: 103 year: 2015 end-page: 108 ident: CR15 article-title: Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2015.02.051 – volume: 12 start-page: 1045 year: 1995 end-page: 1048 ident: CR21 article-title: Compressed donut-shaped tablets with zero-order release kinetics publication-title: Pharm Res doi: 10.1023/A:1016218716951 – volume: 5 start-page: 421 year: 2009 end-page: 427 ident: CR2 article-title: The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets publication-title: J Biomed Nanotechnol doi: 10.1166/jbn.2009.1052 – volume: 530 start-page: 71 year: 2017 end-page: 78 ident: CR9 article-title: Patient acceptability of 3D printed medicines publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.07.064 – volume: 494 start-page: 657 year: 2015 end-page: 663 ident: CR10 article-title: Effect of geometry on drug release from 3D printed tablets publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2015.04.069 – volume: 8 start-page: 1482 year: 1991 end-page: 1488 ident: CR4 article-title: In vitro and in vivo evaluation of whole and half tablets of sustained-release Adinazolam Mesylate publication-title: Pharm Res doi: 10.1023/A:1015834114359 – volume: 57 start-page: 939 year: 2002 end-page: 945 ident: CR3 article-title: Different geometric shaped hydrogel theophylline tablets: statistical approach for estimating drug release publication-title: Farmaco doi: 10.1016/S0014-827X(02)01297-1 – volume: 541 start-page: 101 issue: 1–2 year: 2018 end-page: 107 ident: CR23 article-title: Fabricating 3D printed orally disintegrating printlets using selective laser sintering publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2018.02.015 – volume: 529 start-page: 285 year: 2017 end-page: 293 ident: CR8 article-title: Selective laser sintering (SLS) 3D printing of medicines publication-title: Int J Pharm doi: 10.1016/J.IJPHARM.2017.06.082 – volume: 7 start-page: 237 year: 1999 end-page: 242 ident: CR22 article-title: Release kinetics of coated, donut-shaped tablets for water soluble drugs publication-title: Eur J Pharm Sci doi: 10.1016/S0928-0987(98)00029-3 – volume: 532 start-page: 313 year: 2017 end-page: 317 ident: CR17 article-title: Fabrication of drug-loaded hydrogels with stereolithographic 3D printing publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.09.003 – volume: 89 start-page: 157 year: 2014 end-page: 162 ident: CR18 article-title: 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2014.12.003 – volume: 468 start-page: 172 issue: 1–2 year: 2018 end-page: 177 ident: CR14 article-title: Accelerating the dissolution of enteric coatings in the upper small intestine: Evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.04.019 – volume: 11 start-page: 59 year: 2004 end-page: 65 ident: CR19 article-title: An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers publication-title: Drug Deliv doi: 10.1080/10717540490265379 – volume: 39 start-page: 440 year: 2018 end-page: 451 ident: CR1 article-title: 3D printing pharmaceuticals: drug development to frontline care publication-title: Trends Pharmacol Sci doi: 10.1016/J.TIPS.2018.02.006 – start-page: 3 year: 2012 end-page: 9 ident: CR11 article-title: Photopolymerization and photo-cross-linking publication-title: Photoinitiators for polymer synthesis doi: 10.1002/9783527648245.ch1 – volume: 382 start-page: 56 year: 2009 end-page: 60 ident: CR13 article-title: Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2009.08.003 – volume: 547 start-page: 44 issue: 1–2 year: 2018 end-page: 52 ident: CR24 article-title: 3D printing of drug-loaded gyroid lattices using selective laser sintering publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2018.05.044 – volume: 8 start-page: 1482 year: 1991 ident: 1075_CR4 publication-title: Pharm Res doi: 10.1023/A:1015834114359 – volume: 529 start-page: 285 year: 2017 ident: 1075_CR8 publication-title: Int J Pharm doi: 10.1016/J.IJPHARM.2017.06.082 – volume: 468 start-page: 172 issue: 1–2 year: 2018 ident: 1075_CR14 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.04.019 – volume: 57 start-page: 939 year: 2002 ident: 1075_CR3 publication-title: Farmaco doi: 10.1016/S0014-827X(02)01297-1 – volume: 532 start-page: 313 year: 2017 ident: 1075_CR17 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.09.003 – volume: 39 start-page: 440 year: 2018 ident: 1075_CR1 publication-title: Trends Pharmacol Sci doi: 10.1016/J.TIPS.2018.02.006 – volume: 541 start-page: 101 issue: 1–2 year: 2018 ident: 1075_CR23 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2018.02.015 – volume: 382 start-page: 56 year: 2009 ident: 1075_CR13 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2009.08.003 – volume: 3 start-page: 872 year: 2010 ident: 1075_CR6 publication-title: Int J Pharm Sci Nanotech – volume: 530 start-page: 71 year: 2017 ident: 1075_CR9 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.07.064 – volume: 78 start-page: 151 year: 2011 ident: 1075_CR12 publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2011.01.001 – start-page: 3 volume-title: Photoinitiators for polymer synthesis year: 2012 ident: 1075_CR11 doi: 10.1002/9783527648245.ch1 – volume: 28 start-page: 457 year: 2002 ident: 1075_CR20 publication-title: Drug Dev Ind Pharm doi: 10.1081/DDC-120003007 – volume: 23 start-page: 1547 issue: 8 year: 2018 ident: 1075_CR7 publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2018.05.025 – volume: 484 start-page: 103 year: 2015 ident: 1075_CR15 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2015.02.051 – volume: 503 start-page: 207 year: 2016 ident: 1075_CR16 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2016.03.016 – volume: 11 start-page: 59 year: 2004 ident: 1075_CR19 publication-title: Drug Deliv doi: 10.1080/10717540490265379 – volume: 547 start-page: 44 issue: 1–2 year: 2018 ident: 1075_CR24 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2018.05.044 – volume: 89 start-page: 157 year: 2014 ident: 1075_CR18 publication-title: Eur J Pharm Biopharm doi: 10.1016/j.ejpb.2014.12.003 – volume: 12 start-page: 1045 year: 1995 ident: 1075_CR21 publication-title: Pharm Res doi: 10.1023/A:1016218716951 – volume: 7 start-page: 237 year: 1999 ident: 1075_CR22 publication-title: Eur J Pharm Sci doi: 10.1016/S0928-0987(98)00029-3 – volume: 494 start-page: 657 year: 2015 ident: 1075_CR10 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2015.04.069 – volume: 5 start-page: 421 year: 2009 ident: 1075_CR2 publication-title: J Biomed Nanotechnol doi: 10.1166/jbn.2009.1052 – volume: 49 start-page: 177 year: 2000 ident: 1075_CR5 publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(99)00082-X |
SSID | ssj0023193 |
Score | 2.570184 |
Snippet | Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3355 |
SubjectTerms | Acetaminophen - chemistry Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Drug Liberation Pharmacology/Toxicology Pharmacy Polyethylene Glycols - chemistry Powders Printing, Three-Dimensional Research Article Stereolithography Tablets - chemistry Technology, Pharmaceutical - methods Theme: Printing and Additive Manufacturing |
Title | Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets |
URI | https://link.springer.com/article/10.1208/s12249-018-1075-3 https://www.ncbi.nlm.nih.gov/pubmed/29948979 https://www.proquest.com/docview/2060875156 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZSwMxEB48XnwRb-tFBBGvxd3Nno9FrbcU24I-hd0cKuiudLcP_fdO9miRquB7Dsg3yXyTSb4B2EOKEfvSk4aSFgYobhwaQSwtgwdhbCkhIl7cd9w_eFc95-bJfar-cWf1a_c6JVmc1IUCghmcZjoHpN_2aDlS3zXoNMy6OnRHI-7ZzVGUhTZFq_Tlj92-O6AJVjmRES0cTWsB5iuGSJolpIswJZMl2G-XEtPDE9Id_5jKTsg-aY_Fp4fLEF3XVUdIqsilTD9k3h-SNCHI9Mh5f_BCHtHToO8i7bJcd6YbdnB5pX4K91pKWL9xctC5ax4Sem60-1pTQpCu_mWVZyvQa110z66MqoyCwR3LzA1NERyuvNAWIZci8B0EwAuESanSeURkKJb0eOwoDN1UZEtHRHgK-JalXKqERVdhJkkTuQ6EIx2MfIksQUU4ih0pJGQ0Njl2c2LhN8Cs15bxSmNcl7p4ZzrWQDhYCQdDOJiGg9EGHI26fJYCG3813q0BY7gNdG4jSmQ6yJhtelqbH6PRBqyVSI6GQ4_rBKEfNuC4hpZVOzX7fa6Nf7XehDm7sDF9ObMFM3l_ILeRruTxDsw2L59vL3YKM_0CHHfjfQ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BOcAFsVNWIyHE0ogkTrMcK6AUKKiCVuJmJV4ACRLUpIf-PeMsRYhF4u5F8rM9bzzjNwD7SDEiT7rSUNJCB6UZBYYfScvgfhBZSoiQ5-8dt3duZ-BcPzYfy3_caZXtXoUk85s6V0Aw_dNUx4B0bo-WI_WaBp2GGeQCvs7jGtitiZeFe4qW4csfu301QN9Y5beIaG5o2gswXzJE0iogXYQpGS_BQa-QmB43SP_zx1TaIAek9yk-PV6G8KqqOkISRS5l8iaz4ZgkMUGmR86Hoydyj5YGbRfpFeW6U93wAZdX6lS450LC-oWTw4du64jQc6M31JoSgvT1L6ssXYFB-6J_1jHKMgoGdywzMzRFcLhyA1sEXArfcxAA1xcmpUrHEZGhWNLlkaPQdVOhLR0R4i3gWZZqUiUsugq1OInlOhCOdDD0JLIEFeIodqiQkNHI5NjNiYRXB7NaW8ZLjXFd6uKVaV8D4WAFHAzhYBoORutwPOnyXghs_NV4rwKM4THQsY0wlskoZbbpam1-9EbrsFYgORkOLa7jB15Qh5MKWlae1PT3uTb-1XoXZjv92y7rXt3dbMKcne83_VCzBbVsOJLbSF2yaCffqh_W5-Tc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB4VKiEuVV-U7dOVKgR0I-I4m8dx1e0CLaAIdiVuVuIHRaIJ2mQP--87s04WIdpKXCPbkfyNPd947G8AviDFKGITGc8ajgHKoEi9pDDcU0lacKt1rpbnHadn0dE0_HE5uGzrnNbdbfcuJeneNJBKU9kc3Grr1BD85KCmfBDd8yFp0njgiTV4irsxJ7OeBsNVxIVfRJvK_Gu3-87oAcN8kB1dOp3xc3jWskU2dPC-gCemfAk7mZObXvTZ5O71VN1nOyy7E6JevIL8uKtAwirLDk312zSzBatKhqyPjWbzK3aOXgf9GMtc6e6aGl7gVBu6FvfLyVlfK7Z7cTLcY2LkZTPSl9BsQi-umvo1TMffJ9-OvLakgqdC7jce0YVQ2SgNdKqMTuIQwYgS7QthKaeIbIWbSBWhxTDO5oEJdY47Qsy5HQirudiC9bIqzTYwhdQwjw0yBpvjKEFukZyJwlfYLSx03AO_m1upWr1xKntxIynuQDikg0MiHJLgkKIH-6sut05s43-NP3eASVwSlOfIS1PNaxn4Een0Y2TagzcOydVw6H3DJI3THnztoJXtqq3__a-3j2r9CTay0VieHJ_9fAebwdLc6MzmPaw3s7n5gCymKT4uLfUPEqfpGA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+Geometry+on+the+Drug+Release+Profiles+of+Stereolithographic+%28SLA%29+3D-Printed+Tablets&rft.jtitle=AAPS+PharmSciTech&rft.au=Martinez%2C+Pamela+Robles&rft.au=Goyanes%2C+Alvaro&rft.au=Basit%2C+Abdul+W&rft.au=Gaisford%2C+Simon&rft.date=2018-11-01&rft.issn=1530-9932&rft.eissn=1530-9932&rft.volume=19&rft.issue=8&rft.spage=3355&rft_id=info:doi/10.1208%2Fs12249-018-1075-3&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-9932&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-9932&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-9932&client=summon |